C4 Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
C4 Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2024.
  • C4 Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -354 %, a 48.4% increase year-over-year.
  • C4 Therapeutics, Inc. annual Operating Margin for 2023 was -670 %, a 60.8% decline from 2022.
  • C4 Therapeutics, Inc. annual Operating Margin for 2022 was -417 %, a 132% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -354 +333 +48.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -405 +497 +55.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -674 -180 -36.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -670 -253 -60.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -687 Jul 1, 2023 Sep 30, 2023
Q2 2023 -902 Apr 1, 2023 Jun 30, 2023
Q1 2023 -494 Jan 1, 2023 Mar 31, 2023
Q4 2022 -417 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.